Published in Int J Hematol Oncol Stem Cell Res on January 01, 2013
Leukocytes apoptosis and adipocytokines in children with beta thalassemia major. Clin Exp Med (2015) 0.77
Biochemical Markers of Bone Turnover in Patients with β-Thalassemia Major: A Single Center Study from Southern Pakistan. Adv Hematol (2016) 0.75
Hereditary spherocytosis. Lancet (2008) 2.37
Thalassaemia. Lancet (2011) 1.89
Nutritional deficiencies in iron overloaded patients with hemoglobinopathies. Am J Hematol (2009) 1.42
Hormonal changes in thalassaemia major. Arch Dis Child (1976) 1.36
Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord (2003) 1.33
Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone (2006) 1.18
Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta (2003) 1.17
Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol (2009) 1.15
Hypoparathyroidism in beta-thalassemia major. Clinical and laboratory observations in 24 patients. Acta Haematol (1992) 1.09
Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study. Ital J Pediatr (2010) 1.02
Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data. Metabolism (1998) 0.99
Low bone mineral density in adolescents with beta-thalassemia. Ann N Y Acad Sci (2005) 0.97
Rapid detection of beta-Thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control. Hemoglobin (2007) 0.96
Impact of disordered puberty on bone density in beta-thalassaemia major. Br J Haematol (2003) 0.96
Unbalanced bone turnover in children with beta-thalassemia. Hematology (2006) 0.95
Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab (2003) 0.91
Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugs. J Bone Miner Metab (2004) 0.90
Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major. Int J Clin Pract (2005) 0.90
Serum 25-hydroxyvitamin D levels in thalassaemia. Arch Dis Child (1978) 0.89
Hypocalcemia due to hypoparathyroidism in beta-thalassemia major patients. Ann Saudi Med (2007) 0.89
Calcium homeostasis in 40 adolescents with beta-thalassemia major: a case-control study of the effects of intramuscular injection of a megadose of cholecalciferol. Pediatr Endocrinol Rev (2008) 0.87
Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone (2011) 0.84
Parathyroid hormone, calcitonin and vitamin D metabolites in beta-thalassaemia major. Eur J Pediatr (1986) 0.83
Assessment of thyroid functions and its role in body growth in thalassemia major. Indian Pediatr (1995) 0.82
Bone mineral density in children and young adults with beta-thalassemia trait. J Pediatr Endocrinol Metab (2002) 0.80
Parathyroid and calcium status in patients with thalassemia. Indian J Clin Biochem (2010) 0.78
Retracted Recurrent/Persistent Pneumonia among Children in Upper Egypt. Mediterr J Hematol Infect Dis (2013) 0.77